Synthesis and anti-human immunodeficiency virus type 1 activity of novel 3'-spiro nucleoside analogues of TSAO-T
(1997) Antiviral Chemistry and Chemotherapy — Vol. 8, n° 6, p. 507-517 (1997)
Files
No attached file found for this publication.
Details
- Authors
- Abstract
- Novel 3'-spiro nucleoside analogues of the potent human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) inhibitor TSAO-T have been designed, synthesized and tested for their in vitro antiretroviral activity against HIV-1. In these TSAO analogues the spiro amino-oxathioledioxide moiety was replaced by other spiro moieties that maintained an NH group at the same position as the 4 ''-NH2 group in the prototype compound TSAO-T. Anti-HIV-l activity, although around 100-fold less pronounced than that of the parent TSAO-m(3)T derivative, was observed for the spiro oxazolone derivative. The spiro oxathiazoledioxide compound also showed antiviral activity. The corresponding beta-D-xylofuranosyl analogues were devoid of antiviral activity; this is in accordance with the behaviour of TSAO-m(3)T. None of the test compounds were inhibitory to HIV-2 replication. The markedly decreased potency of the spiro oxathiazoledioxide and oxazolone compounds against HIV-1 replication is in agreement with their decreased anti-HIV-l RT activity.
- Affiliations
Citations
Alvarez, R., Jimeno, M., PerezPerez, M., De Clercq, E., Balzarini, J., & Camarasa, M. (1997). Synthesis and anti-human immunodeficiency virus type 1 activity of novel 3′-spiro nucleoside analogues of TSAO-T. Antiviral Chemistry and Chemotherapy, 8(6), 507-517. https://hdl.handle.net/2078.5/142357 (Original work published 1997)